The oral LD50 of glucosamine in rats is >5000 mg/kg.L32684 Symptoms of an overdose with glucosamine may include nausea, vomiting, abdominal pain, and diarrhea (common side effects of this drug). Severe and life-threatening hypersensitivity reactions to glucosamine may occur in patients with a shellfish allergy or asthma.L32774
Osteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation.A232289 Treatment with chondroprotective drugs, such as glucosamine sulfate may offer additional benefits to nonsteroidal anti-inflammatory drugs treating the painful symptoms of OA. Glucosamine is commonly used over the counter as a treatment for arthritic joint pain, although its acceptance as a medical therapy varies due to contradictory and findings with unclear clinical significance during clinical trials.A231894,A232289 It is currently not approved as a prescription product by the FDA, but is widely available over the counter.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Abciximab | Glucosamine may increase the antiplatelet activities of Abciximab. |
| Eptifibatide | Glucosamine may increase the antiplatelet activities of Eptifibatide. |
| Ticlopidine | Glucosamine may increase the antiplatelet activities of Ticlopidine. |
| Anagrelide | Glucosamine may increase the antiplatelet activities of Anagrelide. |
| Clopidogrel | Glucosamine may increase the antiplatelet activities of Clopidogrel. |
| Tirofiban | Glucosamine may increase the antiplatelet activities of Tirofiban. |
| Pentoxifylline | Glucosamine may increase the antiplatelet activities of Pentoxifylline. |
| Acetylsalicylic acid | Glucosamine may increase the antiplatelet activities of Acetylsalicylic acid. |
| Dipyridamole | Glucosamine may increase the antiplatelet activities of Dipyridamole. |
| Sulfinpyrazone | Glucosamine may increase the antiplatelet activities of Sulfinpyrazone. |
| Cilostazol | Glucosamine may increase the antiplatelet activities of Cilostazol. |
| Ridogrel | Glucosamine may increase the antiplatelet activities of Ridogrel. |
| Epoprostenol | Glucosamine may increase the antiplatelet activities of Epoprostenol. |
| Resveratrol | Glucosamine may increase the antiplatelet activities of Resveratrol. |
| Nimesulide | Glucosamine may increase the antiplatelet activities of Nimesulide. |
| Tesmilifene | Glucosamine may increase the antiplatelet activities of Tesmilifene. |
| Defibrotide | Glucosamine may increase the antiplatelet activities of Defibrotide. |
| Beraprost | Glucosamine may increase the antiplatelet activities of Beraprost. |
| Ibudilast | Glucosamine may increase the antiplatelet activities of Ibudilast. |
| Andrographolide | Glucosamine may increase the antiplatelet activities of Andrographolide. |
| Caplacizumab | Glucosamine may increase the antiplatelet activities of Caplacizumab. |
| Prasugrel | Glucosamine may increase the antiplatelet activities of Prasugrel. |
| Cangrelor | Glucosamine may increase the antiplatelet activities of Cangrelor. |
| Tranilast | Glucosamine may increase the antiplatelet activities of Tranilast. |
| Triflusal | Glucosamine may increase the antiplatelet activities of Triflusal. |
| Ticagrelor | Glucosamine may increase the antiplatelet activities of Ticagrelor. |
| Icosapent ethyl | Glucosamine may increase the antiplatelet activities of Icosapent ethyl. |
| Vorapaxar | Glucosamine may increase the antiplatelet activities of Vorapaxar. |
| Trapidil | Glucosamine may increase the antiplatelet activities of Trapidil. |
| Naftopidil | Glucosamine may increase the antiplatelet activities of Naftopidil. |
| Sarpogrelate | Glucosamine may increase the antiplatelet activities of Sarpogrelate. |
| Ifetroban | Glucosamine may increase the antiplatelet activities of Ifetroban. |
| Nitroaspirin | Glucosamine may increase the antiplatelet activities of Nitroaspirin. |
| Indobufen | Glucosamine may increase the antiplatelet activities of Indobufen. |
| Butylphthalide | Glucosamine may increase the antiplatelet activities of Butylphthalide. |
| Hydroxytyrosol | Glucosamine may increase the antiplatelet activities of Hydroxytyrosol. |
| Ramatroban | Glucosamine may increase the antiplatelet activities of Ramatroban. |
| Picotamide | Glucosamine may increase the antiplatelet activities of Picotamide. |
| Cloricromen | Glucosamine may increase the antiplatelet activities of Cloricromen. |
| Linsidomine | Glucosamine may increase the antiplatelet activities of Linsidomine. |
| Buflomedil | Glucosamine may increase the antiplatelet activities of Buflomedil. |
| Relcovaptan | Glucosamine may increase the antiplatelet activities of Relcovaptan. |
| Maritime pine extract | Glucosamine may increase the antiplatelet activities of Maritime pine extract. |
| Warfarin | Glucosamine may increase the anticoagulant activities of Warfarin. |
| Acenocoumarol | Glucosamine may increase the anticoagulant activities of Acenocoumarol. |
| (R)-warfarin | Glucosamine may increase the anticoagulant activities of (R)-warfarin. |
| R,S-Warfarin alcohol | Glucosamine may increase the anticoagulant activities of R,S-Warfarin alcohol. |
| S,R-Warfarin alcohol | Glucosamine may increase the anticoagulant activities of S,R-Warfarin alcohol. |
| (S)-Warfarin | Glucosamine may increase the anticoagulant activities of (S)-Warfarin. |